Publication:
Evaluation of treatment response and symptom progression in 400 patients with visual snow syndrome.

cris.virtualsource.author-orcidfacb2aff-78f5-4357-b3dd-ff3dfb256962
dc.contributor.authorPuledda, Francesca
dc.contributor.authorVandenbussche, Nicolas
dc.contributor.authorMoreno-Ajona, David
dc.contributor.authorEren, Ozan
dc.contributor.authorSchankin, Christoph Josef
dc.contributor.authorGoadsby, Peter J
dc.date.accessioned2024-10-06T18:54:21Z
dc.date.available2024-10-06T18:54:21Z
dc.date.issued2022-09
dc.description.abstractAIMS To gather information on useful medications to treat visual snow syndrome (VSS) as well as to validate an instrument to assess its clinical severity and the course of the disorder over time. METHODS Four hundred patients with VSS were included in this web-based prospective questionnaire study. All subjects completed a treatment questionnaire and a clinical diary. The first allowed evaluation of the effects of previous medications on visual snow, while the second measured VSS symptoms daily over the course of 30 days. RESULTS Patients commonly reported previous use of medications such as antidepressants, antiepileptics, antibiotics and benzodiazepines. However, none of these drug classes was beneficial for the majority of patients. Recreational drugs and alcohol worsened visual snow symptoms in several reports. Vitamins and benzodiazepines had high therapeutic ratios, although in most cases they did not change the course of VSS.The monthly diary confirmed that the static in VSS is a consistent symptom over time. It also showed that indoor and fluorescent lights have a worse effect on symptoms when compared with natural outdoor lighting. CONCLUSIONS The study confirms clinical experience that medications are generally ineffective in VSS, with the exception of vitamins and perhaps benzodiazepines, which could be beneficial in some patients. The 30-day diary represents a useful tool to measure symptom progression over time, which could be used in future trials on VSS.
dc.description.numberOfPages7
dc.description.sponsorshipUniversitätsklinik für Neurologie
dc.identifier.doi10.48350/161920
dc.identifier.pmid34656983
dc.identifier.publisherDOI10.1136/bjophthalmol-2020-318653
dc.identifier.urihttps://boris-portal.unibe.ch/handle/20.500.12422/58039
dc.language.isoen
dc.publisherBMJ Publishing Group
dc.relation.ispartofThe British journal of ophthalmology
dc.relation.issn1468-2079
dc.relation.organizationDCD5A442BAE0E17DE0405C82790C4DE2
dc.subjecttreatment other visual pathway
dc.subject.ddc600 - Technology::610 - Medicine & health
dc.titleEvaluation of treatment response and symptom progression in 400 patients with visual snow syndrome.
dc.typearticle
dspace.entity.typePublication
dspace.file.typetext
oaire.citation.endPage1324
oaire.citation.issue9
oaire.citation.startPage1318
oaire.citation.volume106
oairecerif.author.affiliationUniversitätsklinik für Neurologie
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.date.licenseChanged2021-12-10 11:55:42
unibe.description.ispublishedpub
unibe.eprints.legacyId161920
unibe.refereedTRUE
unibe.subtype.articlejournal

Files

Original bundle
Now showing 1 - 1 of 1
Name:
Puledda__2021__Evaluation_of_treatment_response.pdf
Size:
469.2 KB
Format:
Adobe Portable Document Format
File Type:
text
License:
https://creativecommons.org/licenses/by-nc/4.0
Content:
published

Collections